These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients. Knights A, Okasha MS, Salih MA, Hirsch SR. Br J Psychiatry; 1979 Dec; 135():515-23. PubMed ID: 394794 [Abstract] [Full Text] [Related]
23. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study. Mayoral-van Son J, de la Foz VO, Martinez-Garcia O, Moreno T, Parrilla-Escobar M, Valdizan EM, Crespo-Facorro B. J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992 [Abstract] [Full Text] [Related]
24. Maintenance treatment of chronic schizophrenic patients. A study with the long-acting thioxanthene derivative, cis(Z)-clopenthixol decanoate-sordinol depot. Dom R, De Mesmaecker L, van den Broucke M, van Hest T, Baro F. Acta Psychiatr Scand; 1978 Apr; 57(4):299-304. PubMed ID: 352094 [Abstract] [Full Text] [Related]
32. An open clinical trial with the long-acting neuroleptic zuclopenthixol decanoate in the maintenance treatment of schizophrenia. Kazi HA. Pharmatherapeutica; 1986 Oct; 4(9):555-60. PubMed ID: 3763650 [Abstract] [Full Text] [Related]